Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
2002 1
2003 1
2005 2
2006 1
2007 1
2008 3
2009 1
2010 2
2011 1
2012 10
2013 7
2014 5
2015 9
2016 5
2017 13
2018 17
2019 12
2020 19
2021 29
2022 21
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Trends in the approval of cancer therapies by the FDA in the twenty-first century.
Scott EC, Baines AC, Gong Y, Moore R Jr, Pamuk GE, Saber H, Subedee A, Thompson MD, Xiao W, Pazdur R, Rao VA, Schneider J, Beaver JA. Scott EC, et al. Among authors: saber h. Nat Rev Drug Discov. 2023 Aug;22(8):625-640. doi: 10.1038/s41573-023-00723-4. Epub 2023 Jun 21. Nat Rev Drug Discov. 2023. PMID: 37344568 Review.
An FDA oncology analysis of antibody-drug conjugates.
Saber H, Leighton JK. Saber H, et al. Regul Toxicol Pharmacol. 2015 Apr;71(3):444-52. doi: 10.1016/j.yrtph.2015.01.014. Epub 2015 Feb 7. Regul Toxicol Pharmacol. 2015. PMID: 25661711
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial.
Liebeskind DS, Saber H, Xiang B, Jadhav AP, Jovin TG, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Ribo M, Cognard C, Sila C, Hassan AE, Smith WS, Saver JL, Nogueira RG; DAWN Investigators. Liebeskind DS, et al. Among authors: saber h. Stroke. 2022 Mar;53(3):742-748. doi: 10.1161/STROKEAHA.121.034471. Epub 2021 Nov 3. Stroke. 2022. PMID: 34727737 Clinical Trial.
Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis.
Sriwastava S, Kataria S, Srivastava S, Kazemlou S, Gao S, Wen S, Saber H, Tripathi R, Sheikh Z, Peterson S, Gwinn R, Bernitsas E. Sriwastava S, et al. Among authors: saber h. J Neuroimmunol. 2021 Nov 15;360:577721. doi: 10.1016/j.jneuroim.2021.577721. Epub 2021 Sep 15. J Neuroimmunol. 2021. PMID: 34547511 Free PMC article.
Clinical trials of neurointervention : 2007-2018.
Saber H, Jadhav AP, Rajah GB, Narayanan S, Sheth SA, Liebeskind DS, Somai M. Saber H, et al. J Neurointerv Surg. 2019 Dec;11(12):1277-1282. doi: 10.1136/neurintsurg-2019-015117. Epub 2019 Sep 17. J Neurointerv Surg. 2019. PMID: 31530656 Review.
The endocannabinoid system and stroke: A focused review.
Kolb B, Saber H, Fadel H, Rajah G. Kolb B, et al. Among authors: saber h. Brain Circ. 2019 Jan-Mar;5(1):1-7. doi: 10.4103/bc.bc_29_18. Epub 2019 Mar 27. Brain Circ. 2019. PMID: 31001593 Free PMC article. Review.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Cui W, Rocconi RP, Thota R, Anderson RA, Bruinooge SS, Comstock IA, Denduluri N, Gassman A, Gralow J, Hutt KJ, Amiri-Kordestani L, Lambertini M, Leighton J, Lu KH, Mostoufi-Moab S, Pollastro T, Pradhan S, Saber H, Schenkel C, Spratt D, Wedam S, Phillips KA. Cui W, et al. Among authors: saber h. Lancet Oncol. 2023 Oct;24(10):e415-e423. doi: 10.1016/S1470-2045(23)00390-X. Lancet Oncol. 2023. PMID: 37797647 Review.
The genus Turbinaria: chemical and pharmacological diversity.
Rushdi MI, Abdel-Rahman IAM, Saber H, Attia EZ, Abdelraheem WM, Madkour HA, Abdelmohsen UR. Rushdi MI, et al. Among authors: saber h. Nat Prod Res. 2021 Nov;35(22):4560-4578. doi: 10.1080/14786419.2020.1731741. Epub 2020 Feb 24. Nat Prod Res. 2021. PMID: 32091241 Review.
155 results